PT  - JOURNAL ARTICLE
AU  - Gupta, Saptorshi
AU  - Thornley, Simon
AU  - Morris, Arthur
AU  - Sundborn, Gerhard
AU  - Grant, Cameron
TI  - Prevalence and determinants of scabies: a global systematic review and meta-analysis
AID  - 10.1101/2024.05.06.24306963
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.05.06.24306963
4099  - http://medrxiv.org/content/early/2024/05/07/2024.05.06.24306963.short
4100  - http://medrxiv.org/content/early/2024/05/07/2024.05.06.24306963.full
AB  - Background Scabies is a neglected skin disease that disproportionately affects people from resource poor and overcrowded countries. Global data on prevalence and risk factors are limited.Methods Databases (PubMed, Scopus and Google Scholar) were accessed to identify observational studies about scabies published between 2000 and 2023. Results were pooled to estimate prevalence and identify factors which explained between-study heterogeneity. Odds ratios, risk of bias, subgroup analyses and meta-regression were used to describe variation in effect size and heterogeneity based on country-level demographic and economic variables.Findings Fifty-four studies yielded a pooled prevalence of 14.0% (95% confidence interval [CI] 11.4-17.1%) with substantial heterogeneity (I2 = 100%; τ2 = 0.77). Prevalence was higher in Oceania (18.2%; 95% CI 14.1-23.1) compared to other regions. Pooled risk factors for scabies showed significant associations for behavioral factors including contact with someone with itch (odds ratio [OR] 9.26; 95% CI 2.94-29.2), no use of soap (OR 3.42; 95% CI 2.80-4.18), infrequent bathing (OR 2.68; 95% CI 1.76-4.08), bed-sharing (OR 2.57; 95% CI 1.33-4.96), clothes sharing (OR 2.40; 95% CI 1.39-4.13), treated water source (OR 2.29; 95% CI 1.67-3.15) and presence of pets (OR 2.19; 95% CI 1.54-3.11). Socio-economic factors were not convincingly associated with scabies prevalence.Conclusion Prevalence of scabies is associated with geographic location and behavioural factors, but not between-country socioeconomic status. This study identifies risk factors for which targeted behavioural interventions addressing interpersonal interaction, personal hygiene practices and specific treatments related to scabies create the potential to reduce scabies disease burden.WHAT IS ALREADY KNOWN ON THIS TOPIC?WHAT IS ALREADY KNOWN ON THIS TOPIC?Systematic reviews of scabies prevalence have identified Oceania as the global region with the highest disease burden. However, studies identifying risk factors for scabies have been conducted only among local populations. Identification of the most important socioeconomic and behavioural determinants of scabies at a global level is necessary to help identify and prioritise public health interventions.WHAT THIS STUDY ADDS?WHAT THIS STUDY ADDS?This updated systematic review and meta-analysis estimates a global pooled prevalence of scabies using data from 54 studies conducted in 23 countries. The pooled prevalence of scabies was 14%, with the greatest burden in the Western Pacific region. Rather than socio-economic conditions, behavioural practices including contact with a person with itch, bed and sharing of clothes, daily hygienic practices and presence of pets were identified as risk factors for scabies.HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY?HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY?Our study provides an updated estimate on the global burden of scabies and identifies specific behaviours and practices thar are associated with the risk of scabies. The high prevalence indicates the need to consider population level interventions such as mass-drug administration. Health promotion related to risk factors that involve interpersonal interactions and personal hygiene practices has the potential to prevent scabies and its sequelae.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript